Гематология
1496 статей · 38 журналов
Журналы подкатегории (38)
- Annals of Thoracic Surgery Short Reports · Elsevier (99)
- Blood Advances · Elsevier (99)
- Journal of Thrombosis and Haemostasis · Elsevier (95)
- Research and Practice in Thrombosis and Haemostasis · Elsevier (89)
- British Journal of Haematology · Wiley (80)
- Thrombosis Research · Elsevier (80)
- European Journal of Haematology · Wiley (79)
- Blood · Elsevier (75)
- Clinical Lymphoma, Myeloma & Leukemia · Elsevier (71)
- Vox Sanguinis · Wiley (70)
- Transfusion and Apheresis Science · Elsevier (69)
- Radiotherapy & Oncology · Elsevier (66)
- Annals of Oncology · Elsevier (64)
- Haemophilia · Wiley (63)
- American Journal of Hematology · Wiley (58)
- Transfusion · Wiley (54)
- Hematology/Oncology Clinics of North America · Elsevier (50)
- Transfusion Medicine Reviews · Elsevier (39)
- Seminars in Hematology · Elsevier (37)
- Seminars in Oncology · Elsevier (29)
- The Lancet Haematology · Elsevier (28)
- Experimental Hematology · Elsevier (22)
- Transfusion Medicine · Wiley (18)
- HemaSphere · Wiley (17)
- Thrombosis Update · Elsevier (15)
- Journal of Clinical Apheresis · Wiley (12)
- Blood Cancer Journal · Springer Nature (7)
- Leukemia · Springer Nature (7)
- Ca-A Cancer Journal for Clinicians · Wiley (4)
- Annals of Hematology · Springer Nature (0)
- Blood Research · Springer Nature (0)
- Experimental Hematology & Oncology · Springer Nature (0)
- Indian Journal of Hematology and Blood Transfusion · Springer Nature (0)
- International Journal of Clinical Oncology · Springer Nature (0)
- International Journal of Hematology · Springer Nature (0)
- Medical Oncology · Springer Nature (0)
- Thrombosis Journal · Springer Nature (0)
- memo - Magazine of European Medical Oncology · Springer Nature (0)
-
HCT‐FS‐Defined Frailty Is Associated With Lower Survival Across Diverse Hematologic Diagnoses After Allogeneic Transplantation
ABSTRACT Objectives To evaluate whether Hematopoietic Cell Transplantation Frailty Scale (HCT‐FS)‐defined frailty predicts overall survival (OS), nonrelapse mortality (NRM), and relapse across diverse hematologic diagnoses undergoing...
- When Bleeding Signals Therapeutic Success: Early Response and Maintenance Therapy With Plasma‐Derived Human Plasminogen Replacement in Two Patients With Type 1 Plasminogen Deficiency
-
Emicizumab Prophylaxis in Patients With Acquired Hemophilia A During Immunosuppressive Therapy: Real‐World Data From the Spanish Acquired Hemophilia Registry
Abstract Introduction Acquired hemophilia A (AHA) is a rare bleeding disorder in which immunosuppressive therapy (IST) and hemostatic management remain challenging, particularly in elderly patients. Evidence supporting emicizumab use in...
-
Sharps Disposal Practices and Associated Factors Among Adults With Hemophilia Receiving Home‐Based Treatment
ABSTRACT Background The increasing use of home‐based parenteral therapies has made the safe management of sharps waste a significant public health concern. Aim This study aimed to evaluate sharps use and disposal practices among...
- Gene Therapy for Haemophilia: A Lived Experience Model to Guide Psychosocial Support Across the Whole Haemophilia Community in the Era of Gene Therapy
- Ultrasound Versus Magnetic Resonance Imaging for Haemophilic Arthropathy: A Systematic Review With Meta‐Analysis of Diagnostic Accuracy Across Joint Pathologies
- Arthroplasty After Hemophilia Gene Therapy: Perioperative Implications and Clinical Experience
-
Clinical Experience of Iptacopan in Paroxysmal Nocturnal Hemoglobinuria
ABSTRACT Iptacopan, an oral Factor B inhibitor, is approved for the treatment of paroxysmal nocturnal hemoglobinuria (PNH). In clinical trials it was safe and effective but real‐world data, particularly in patients with associated bone...
-
Prevalence of seropositivity for Trypanosoma cruzi in blood donors: A 10‐year analysis in southern Brazil
Abstract Background and Objectives Chagas disease, caused by the protozoan Trypanosoma cruzi , remains a major public health challenge in Latin America and is increasingly gaining global relevance. This study aimed to analyze the...
-
Prevalence of occult hepatitis B infection among blood donors from 2015 to 2025: A meta‐analysis based on testing modalities and temporal trends
Abstract Background and Objectives Occult hepatitis B infection (OBI) remains an important concern for global blood safety. Published studies have reported inconsistent OBI prevalence among blood donors, and the influencing factors...
-
Integrated Multi‐Omic Characterization of Hexokinase‐1 Deficiency in Red Blood Cells Reveals Altered Redox Homeostasis, Membrane Remodeling, and Features of Incomplete Erythroid Maturation
ABSTRACT Hexokinase 1 (HK1) deficiency is a rare cause of hereditary nonspherocytic hemolytic anemia characterized by impaired erythrocyte glycolysis, but its broader molecular consequences of HK1 dysfunction remain poorly understood....
-
Prognostic Impact of FLT3‐ITD Allelic Ratio in AML Patients Treated With High‐Dose Anthracycline and a FLT3 Inhibitor
ABSTRACT The prognostic value of FLT3 internal tandem duplication ( FLT3 ‐ITD) in acute myeloid leukemia (AML) has traditionally been stratified according to the ITD/wild‐type allelic ratio (AR) and NPM1 co‐mutation status. We evaluated...
-
Circulating Biomarkers Associated With Hereditary Hemorrhagic Telangiectasia Sensitive to ALK1 Modulation
This article published in Early View in error. The article is under embargo and will republish on 15th December 2026.
- Increased Risk of Subsequent Cancers in Patients With Sézary Syndrome
-
Efficacy and Safety of Doxorubicin–Etoposide–Methylprednisolone (DEP)‐Based Regimens in Haemophagocytic Lymphohistiocytosis: A Systematic Review and Meta‐Analysis
ABSTRACT Background Haemophagocytic lymphohistiocytosis (HLH) is a rare but severe hyperinflammatory syndrome caused by uncontrolled immune activation. Etoposide‐containing regimens are established in paediatric HLH, but evidence in...
-
New Drugs in Myelofibrosis: Incremental Progress in Symptom Management Without Disease Modification
ABSTRACT Janus kinase inhibitors are the cornerstone of treatment for myelofibrosis, but have limited disease‐modifying activity. Combinations of ruxolitinib with pelabresib, navitoclax, or selinexor improve spleen responses, although...
- Heritability of Transcranial Doppler Velocity in Sickle Cell Anemia Across Two Independent Pediatric Cohorts
-
From contamination to fever: The role of endotoxin levels in bacterially contaminated platelet concentrates
Abstract Background and Objectives Growth of gram‐negative bacteria in a platelet concentrate (PC) is inevitably accompanied by the accumulation of endotoxin, which is the major component of the outer cell membrane of these organisms....
-
Ensuring a reliable blood supply during a pandemic in a Caribbean setting: The Curaçao experience
Abstract Background and Objectives National blood systems require a resilient mechanism for ensuring safe blood supply during pandemics. For small island developing states (SIDS) additional specific challenges exist not normally...
-
A content‐validated framework for a patient blood management toolkit for South Africa: A mixed‐methods e‐Delphi study
Abstract Background and Objectives South African hospitals face a high anaemia burden, variable access to patient blood management (PBM) modalities and uneven adoption of evidence‐informed transfusion practice. Pragmatic,...
- Longevity in Thalassemia: Which Clock Are We Trying to Slow?
-
Impact of nationwide parvovirus B19 DNA screening and identification of transfusion‐transmitted infections
Abstract Background and Objectives Parvovirus B19 (B19V) testing is often not required to release blood components. However, the European Pharmacopoeia requires that plasma pools for fractionation contain no more than 10 4 IU/mL of B19V...
-
Outcomes of Patients With AL Amyloidosis and End‐Stage Renal Disease After Initiation of Therapy
ABSTRACT In AL amyloidosis, advanced renal disease can impact treatment options and cause significant morbidity. Patients with ESRD requiring dialysis are a group with currently unmet needs. In this collaborative study, we identified...
- Voxelotor in Children With Conditional Cerebral Blood Flow Velocity: What HOPE Kids 2 Teaches Us About Efficacy, Mortality, and Malaria Risk in Africa
-
Maternal immunoglobulin G anti‐A and anti‐B antibody titres for predicting neonatal immune sensitisation in ABO‐incompatible pregnancies: The Maternal Anti‐A and Anti‐B Antibody Titres in ABO‐Incompatible Pregnancies study
Abstract Background and Objectives Maternal immunoglobulin G (IgG) anti‐A and anti‐B antibodies can cross the placenta and cause ABO haemolytic disease of the foetus and newborn (ABO‐HDFN). We aimed to evaluate whether maternal IgG...
-
Red cells stored in non‐DEHP containers: The effect of washing, irradiation or storage as paediatric units on in vitro quality parameters
Abstract Background and Objectives In accordance with European Union (EU) regulations, the use of the polyvinyl chloride (PVC) plasticiser diethylhexyl phthalate (DEHP) in medical devices must be phased out by 2030 in the EU. We...
- Access to hepatitis B immunoglobulin in Burkina Faso
-
Comprehensive analysis of Lewis antigen expression patterns in a Chinese blood donor cohort
Abstract Background and Objectives To characterise FUT2 and FUT3 haplotype and genotype frequencies among 529 Shanghai Han voluntary blood donors, and quantify erythrocyte Leᵃ and Leᵇ expression via flow cytometry. This study extends...
- Issue Information
- Abstracts from The Shot Symposium 2026